Yayun Liang Selected Research

Breast Diseases (Breast Disease)

8/2012	Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
10/2007	Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yayun Liang Research Topics

Disease

27	Neoplasms (Cancer) 02/2022 - 08/2003
26	Breast Neoplasms (Breast Cancer) 02/2022 - 08/2003
7	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2005
3	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 12/2002
2	Triple Negative Breast Neoplasms 01/2019 - 01/2017
2	Breast Diseases (Breast Disease) 08/2012 - 10/2007
1	Ischemia 01/2011
1	Lymphatic Metastasis 09/2010

Drug/Important Bio-Agent (IBA)

18	Estrogens (Estrogen)FDA Link 01/2019 - 08/2003
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2005
13	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2005
13	Progestins (Progestagens)IBA 01/2017 - 02/2005
12	Hormones (Hormone)IBA 02/2022 - 08/2003
8	Progesterone CongenersIBA 01/2017 - 02/2005
7	Estrogen ReceptorsIBA 02/2022 - 08/2003
6	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 02/2005
6	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2017 - 10/2007
5	EnzymesIBA 02/2022 - 07/2014
5	Ro 48-8071IBA 02/2022 - 04/2011
5	CholesterolIBA 02/2022 - 07/2014
5	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
5	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 04/2011 - 10/2007
4	LigandsIBA 02/2022 - 02/2005
4	Fulvestrant (Faslodex)FDA Link 09/2009 - 04/2004
3	FumaratesIBA 02/2022 - 07/2014
3	lanosterol synthaseIBA 02/2022 - 07/2014
3	Norethindrone (Norethisterone)FDA LinkGeneric 01/2017 - 09/2010
3	SteroidsIBA 01/2016 - 09/2006
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2015 - 01/2012
3	Messenger RNA (mRNA)IBA 10/2014 - 02/2005
3	Estradiol (Delestrogen)FDA LinkGeneric 09/2010 - 04/2004
3	Thrombospondin 1IBA 09/2009 - 04/2004
3	Mifepristone (RU 486)FDA Link 09/2006 - 12/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006 - 02/2005
2	Estrogen Receptor betaIBA 02/2022 - 10/2007
2	lissamine rhodamine B (sulforhodamine B)IBA 02/2022 - 07/2014
2	eprenetapoptIBA 01/2019 - 01/2018
2	PhosphatidylserinesIBA 01/2019 - 01/2018
2	Aldehyde DehydrogenaseIBA 01/2017 - 01/2015
2	LuteolinIBA 01/2017 - 01/2015
2	FlavonoidsIBA 01/2015 - 08/2012
2	Biological ProductsIBA 10/2014 - 09/2010
2	AndrogensIBA 10/2014 - 12/2002
2	Conditioned Culture MediaIBA 09/2009 - 08/2005
2	Tamoxifen FDA LinkGeneric 12/2005 - 12/2002
1	liquiritigeninIBA 02/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019
1	Tumor Suppressor Protein p53IBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	ImmunosorbentsIBA 01/2015
1	Fluvastatin FDA Link 07/2014
1	Simvastatin (Zocor)FDA LinkGeneric 07/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	3- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazoleIBA 01/2013
1	RANK LigandIBA 08/2012
1	ApigeninIBA 08/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2012
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2011
1	Adenosine Triphosphate (ATP)IBA 12/2011
1	Complement System Proteins (Complement)IBA 12/2011
1	Therapeutic UsesIBA 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011
1	Norgestrel (DL-Norgestrel)FDA LinkGeneric 09/2010
1	Progesterone FDA LinkGeneric 09/2010
1	Extracellular Matrix ProteinsIBA 09/2009
1	matrigelIBA 10/2007
1	Angiogenesis InhibitorsIBA 10/2007
1	Estrogen Receptor alphaIBA 10/2007
1	progesterone receptor BIBA 12/2005
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2005
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2003
1	afimoxifene (hydroxytamoxifen)IBA 08/2003
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2002

Therapy/Procedure

17	Therapeutics 02/2022 - 08/2003
6	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2017 - 08/2005
3	Contraception (Birth Control) 09/2010 - 08/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
1	Castration 01/2016
1	Aftercare (After-Treatment) 01/2011
1	Injections 09/2010
1	Estrogen Replacement Therapy 10/2007